8th International Conference on HLA-G July 8th – 9th 2019 Ministère de la Santé et des Solidarités, Paris, France Invectys will be attending the 8th International…
Invectys élu « meilleur projet – jeune entreprise » 2019 par le Board international de MATWIN Invectys, société biopharmaceutique développant des thérapies…
Healthtech Investor Day June 24th – 25th, 2019 The Peninsula Paris, Paris, France Pierre Langlade-Demoyen, our CEO, will be representing Invectys…
The main product of Invectys is a DNA vaccine targeting Telomerase…
The telomerase enzyme functions as part of a large ensemble of proteins and RNA called the telomerase ribonucleoprotein complex.…
Monoclonal antibodies targeting checkpoint inhibitors are hugely important immunotherapy molecules for the treatment cancers…
